C12Y 114/15
Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen
Official title: with reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen (1.14.15)
C12Y114/15 (Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen) appears on 69 US grants and 99 published applications in this corpus.
Search patents in C12Y- Granted patents
- 69
- Published applications
- 99
- Assignees
- 64
- Inventors
- 262
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 2 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 2 |
| 2012 | 2 | 1 |
| 2013 | 2 | 3 |
| 2014 | 2 | 4 |
| 2015 | 3 | 8 |
| 2016 | 3 | 7 |
| 2017 | 5 | 9 |
| 2018 | 4 | 6 |
| 2019 | 9 | 9 |
| 2020 | 4 | 6 |
| 2021 | 6 | 7 |
| 2022 | 2 | 6 |
| 2023 | 4 | 6 |
| 2024 | 4 | 6 |
| 2025 | 4 | 7 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 114/15003Alkane 1-monooxygenase36
- C12Y 114/15006Cholesterol monooxygenase , i.e. cytochrome p450scc18
- C12Y 114/15004Steroid 11-beta-monooxygenase8
- C12Y 114/15001Camphor 5-monooxygenase7
- C12Y 114/15802Spheroidene monooxygenase , i.e. acyclic carotenoid 2-ketolase2
- C12Y 114/15005Corticosterone 18-monooxygenase0
- C12Y 114/15007Choline monooxygenase0
- C12Y 114/15008Steroid 15-beta-monooxygenase0
Recent patents
- Gene encoding cytochrome P450 and use thereof19 May 2026US 12,630,829 B2Kumiai Chemical Industry Co., Ltd.
- Methods of producing omega-hydroxylated fatty acid derivatives7 Apr 2026US 12,595,495 B2Genomatica, Inc.
- Targeted expression of microbial cholesterol catalysis genes reduces excess lipid10 Feb 2026US 12,544,402 B2Repair Biotechnologies, Inc.
- Enabling cholesterol catabolism in mammalian cells lacking same10 Feb 2026US 12,545,918 B2University of South Alabama Foundation for Research and Commercialization
- Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof25 Mar 2025US 12,258,588 B2Hangzhou Enhe Biotechnology Co., Ltd.
- Gene combination and method for biosynthesis of crocins27 Aug 2026US 2026/0250702 A1Shanghai Academy of Agricultural Sciences
- Gene encoding cytochrome p450 and use thereof30 Jul 2026US 2026/0218206 A1Kumiai Chemical Industry Co., Ltd.
- Fusion protein crtzw and application in catalyzing production of astaxanthin from carotene7 May 2026US 2026/0125658 A1Yunnan Vitasource Biological Technology Co., LTD.
- In Vitro Bioproduction of Polyalkanoates from Polypropylene and Polyethylene16 Apr 2026US 2026/0103734 A1Kimberly-Clark Worldwide, Inc.
- In Vitro Bioproduction of Specific Chain Legnth Poly(hydroxyalkanoate) Monomers9 Apr 2026US 2026/0098283 A1Kimberly-Clark Worldwide, Inc.
Most cited
By later US patents
- Recombinant host cells comprising phosphoketolases35US 8,871,488 B2Butamax Advanced Biofuels LLC · 2014
- Regioselective alkane hydroxylation with a mutant CYP153A6 enzyme32US 8,361,769 B1U. S. Department of Energy · 2013
- Microbial enhanced oil recovery methods21US 8,316,933 B2Geo Fossil Fuels, LLC · 2012
- Yeast strains autonomously producing steroids13US 7,670,829 B2Aventis Pharma S. A. · 2010
- Cholesterol disposal fusion enzymes12US 5,547,868 AThe Regents of the University of California · 1996